Bunkerhill ECG-EF vs Cleerly ISCHEMIA

Similar category, different focus. These tools serve overlapping but distinct needs. Comparability 60/100 Comparability is an AI-graded 0–100 score of how directly these two tools compete — higher means a more apples-to-apples comparison.

Bunkerhill ECG-EF

by Bunkerhill Health

Cleerly ISCHEMIA

by Cleerly

AI Verdict

Tool A, Bunkerhill ECG-EF, focuses on detecting reduced left ventricular ejection fraction from ECGs to identify heart failure risk. In contrast, Tool B, Cleerly ISCHEMIA, analyzes CCTA scans to determine the likelihood of coronary artery ischemia and characterize plaque. While both are cardiology AI tools, they utilize different diagnostic modalities and address distinct aspects of cardiac health, making them adjacent rather than direct competitors.

Choose Bunkerhill ECG-EF if…

Choose Bunkerhill ECG-EF if you need a rapid, non-invasive, and broadly accessible tool for early identification of patients at risk for heart failure using routine 12-lead electrocardiograms. This AI algorithm is ideal for screening large populations or in settings like emergency departments and primary care where quick risk stratification for reduced left ventricular ejection fraction is crucial, leveraging existing ECG infrastructure.

View Bunkerhill ECG-EF →

Choose Cleerly ISCHEMIA if…

Choose Cleerly ISCHEMIA if you require a detailed, non-invasive assessment of coronary artery ischemia and plaque characteristics from CCTA scans to inform personalized diagnosis and treatment planning. This tool is best suited for patients undergoing evaluation for suspected or known coronary artery disease, where comprehensive vessel-level analysis, including fractional flow reserve estimation and stenosis severity, is needed to guide clinical decisions.

View Cleerly ISCHEMIA →

Reviewed by Pouyan Golshani, MD — Interventional Radiologist

Quick Comparison

Feature	Bunkerhill ECG-EF	Cleerly ISCHEMIA
Pricing	Contact sales for pricing details.	Contact for details
Deployment	Cloud-native platform (Carebricks) that integrates with existing health system infrastructure like EHRs.	Web-based platform; data transfer via Cleerly Proxy (VPN or virtual appliance)
FDA Status	Yes AI-estimated	1 AI-estimated
HIPAA	Yes AI-estimated	Unknown

Feature-by-Feature

Detail beyond the Quick Comparison summary. For pricing, deployment, BAA, FDA, and HIPAA see the Overview tab.

Feature	Bunkerhill ECG-EF	Cleerly ISCHEMIA
Name	Bunkerhill ECG-EF	Cleerly ISCHEMIA
Company	BunkerHill Health	Cleerly
Description	FDA-cleared artificial intelligence algorithm by BunkerHill Health that detects reduced left ventricular ejection fraction (LVEF u2264 40%) from routine 12-lead electrocardiograms (ECGs), aiding in the early identification of patients at risk for heart failure.	FDA-cleared AI tool that analyzes CCTA scans to non-invasively determine the likelihood of coronary artery ischemia at a vessel level, aiding physicians in personalized diagnosis and treatment planning for heart disease.
Primary Data Input	Routine 12-lead electrocardiograms (ECGs)	CCTA scans
Key Detection/Analysis	Reduced Left Ventricular Ejection Fraction (LVEF u2264 40%)	Likelihood of coronary artery ischemia at a vessel level
Specialties	Cardiology, Emergency Medicine, Internal Medicine	Cardiology, Radiology

Videos

Demos, reviews, and walkthroughs featuring Bunkerhill ECG-EF and Cleerly ISCHEMIA.

Loading videos…

Videos need JavaScript to load. Search YouTube directly →

View all on YouTube

Frequently Asked Questions

What are the primary clinical applications of Bunkerhill ECG-EF and Cleerly ISCHEMIA?

Bunkerhill ECG-EF is an AI algorithm that detects reduced left ventricular ejection fraction (LVEF u2264 40%) from routine 12-lead ECGs, aiding in the early identification of patients at risk for heart failure. Cleerly ISCHEMIA is an AI tool that analyzes CCTA scans to non-invasively determine the likelihood of coronary artery ischemia at a vessel level, assisting physicians in personalized diagnosis and treatment planning for heart disease.

What type of patient data is required for each tool?

Bunkerhill ECG-EF analyzes data from routine 12-lead electrocardiograms (ECGs). Cleerly ISCHEMIA analyzes coronary computed tomography angiography (CCTA) scans.

How do these tools integrate into existing clinical workflows?

Bunkerhill ECG-EF integrates seamlessly with Electronic Health Records (EHRs) and clinical archives or ECG Management Systems (EMS). Cleerly ISCHEMIA is a web-based platform with data transfer via Cleerly Proxy (VPN or virtual appliance) and offers integration with PowerScribe via API.

What specific cardiac insights or metrics do these tools provide?

Bunkerhill ECG-EF provides detection of reduced Left Ventricular Ejection Fraction (LVEF u2264 40%). Cleerly ISCHEMIA offers vessel-level ischemia likelihood determination, non-invasive fractional flow reserve (FFR) estimation, coronary plaque characterization (volume, type, location), and stenosis severity assessment, presented in comprehensive interactive web-based reports.

Which medical specialties are these tools primarily designed for?

Bunkerhill ECG-EF is designed for Cardiology, Emergency Medicine, and Internal Medicine. Cleerly ISCHEMIA is designed for Cardiology and Radiology.

More Comparisons

Assert-IQ vs Rapid Enterprise Platform

AISAP Cardio vs Rapid Enterprise Platform

AngioWaveNet vs Rapid Enterprise Platform

CorVista System with PH Add-On vs Rapid Enterprise Platform

More matchups featuring Bunkerhill ECG-EF or Cleerly ISCHEMIA

Backers

Who funded each tool's parent company.